- Grant support from the Bill & Melinda Gates Foundation will
extend Sibel Health's AI-enabled, and FDA-cleared ANNE® One
monitoring solution to improve maternal health monitoring
globally
- Sibel Health partners with the University
of Edinburgh and the National Institute for Health and Care
Research (NIHR) Global Health Research Unit on Global Surgery
(Global Surgery Unit) to develop solutions in collaboration with
leading Indian, Pakistani, and Nigerian institutes.
CHICAGO, April 23,
2024 /PRNewswire/ -- Sibel Health, an
award-winning health technology company backed by the Steele
Foundation for Hope, announced it has received a $17.5 million dollar grant from the Bill &
Melinda Gates Foundation to advance the use of its FDA-cleared
wireless monitoring solution, ANNE® One, for labor triage and
continuous maternal health monitoring in low-and-middle income
countries (LMICs) to reduce obstetrical morbidity and mortality.
With more than 12,000 pregnancies monitored in LMICs already, Sibel
Health is positioned to develop new purpose-built products in
partnership with the University of
Edinburgh and the NIHR Global Surgery Unit. The ANNE® One
platform is an FDA-cleared platform capable of monitoring all vital
signs in home and hospital settings for patients 12 years and older
powered by AI-enabled advanced wearable sensors. It is Sibel's
4th FDA clearance since 2021.
"Sibel Health was spun out of Northwestern
University and founded from an initial grant from the Bill
& Melinda Gates Foundation given our commitment to maternal
neonatal health. We're proud to come full circle to take that
initial investment and expand our potential for impact. Losing a
single mother while giving birth is one too many. Vital signs are
vital—and every pregnant person deserves to have their vitals
checked," said Steve Xu MD, CEO and
Co-Founder of Sibel Health. "We're looking forward to adding
AI-driven clinical decision support and point of care ultrasound to
this platform to go well beyond monitoring in the near future ."
Sibel Health, founded in 2018, has been committed to maternal
health innovation being recognized by the Health Resources and
Services Administration as a Phase 2 winner in their Remote
Pregnancy Monitoring Grand Challenge, and most recently a finalist
in the NIH's Rapid Acceleration of Diagnostics Technology (RADx®
Tech) for Maternal Health Challenge.
Since 2016, progress in reducing global obstetrical mortality
has stalled. Currently, the goal of meeting the UN's 2030
Sustainable Development Goals of reducing maternal mortality rate
to fewer than 70 out of 100,000 births is at risk. Globally, 800
women die every day in pregnancy or childbirth with the majority of
these deaths being completely preventable with early detection by
vital signs monitoring. In the U.S., maternal mortality has
increased in the last 10 years, with black women having 3 times the
risk of death compared to white women.
The University of Edinburgh is a
global institution that co-leads the NIHR Global Surgery Unit. The
Global Surgery Unit holds the Guinness Book of World Records as the
largest biomedical collaboration ever—and will collaborate closely
with Sibel Health to develop and deploy advanced maternal
monitoring in 3 initial target geographies—India, Pakistan, and Nigeria. "As experts in implementing complex
interventions and conducting large-scale clinical trials, we look
forward to working with Sibel Health in this critical effort" said
Professor Ewen Harrison, Professor
of Surgery and Data Science at the University
of Edinburgh, Consultant Hepatobiliary and Transplant
Surgeon at the Royal Infirmary of Edinburgh, and co-lead of the NIHR Global
Surgery Unit. Dr. Rosie Townsend,
Senior Clinical Research Fellow at the University of Edinburgh and Consultant Obstetrician
at the Royal Infirmary of Edinburgh, added "the need for vital signs
monitoring is clear in maternal health for low resource settings,
this is an opportunity to deliver a potentially life-saving
solution."
Most recently, the Gates Foundation has invested more than
$100 million dollars in bringing
point of care ultrasound to LMICs for maternal health. This work
extends into advanced continuous vital signs monitoring engaging
leading experts based in Nigeria
(Doctors Opeyemi Akinajo,
Bosede Afolabi, and Adesoji Ademuyiwa), Pakistan (Doctors Zahra Hoodbhoy, Imran
Nisar, and Fyezah Jehan), and India (Doctors Dhruva
Ghosh and Kavita Mandrelle
Bhatti) as equal partners.
About Sibel Health:
Sibel Health is an award-winning digital health company with a
mission to deliver Better Health Data for All®. Based
in Chicago with an international office in Seoul,
the company's FDA-cleared ANNE® platform includes advanced wearable
sensors, AI-enabled data analytics, and an integrated mobile
software and cloud platform. Sibel has partnerships with some of
the most respected healthcare organizations worldwide. For more
information, please visit us at www.sibelhealth.com and
follow us on LinkedIn.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/sibel-health-awarded-a-major-grant-to-advance-maternal-monitoring-solution-for-low-and-middle-income-countries-302123964.html
SOURCE Sibel Health